A 'Test & Treat' Prevention Strategy in Australia Requires Innovative HIV Testing Models
OBJECTIVES:
HIV
diagnoses among men who have sex with men (MSM) in several high-income
countries, including Australia, have increased substantially over recent years.
Australia, in line with global prevention strategies, has emphasised a 'test
and treat' HIV prevention strategy which relies on timely detection of HIV
through frequent testing by those at risk. We examined trends in repeat testing
among MSM defined as 'high-risk' according to Australian testing guidelines.
METHODS:
HIV test
records from MSM attending high caseload clinics in Melbourne 2007-2013 and
classified as high-risk were analysed. Binary outcomes of 'test within 3 months'
and 'test within 6 months' were assigned to tests within individuals' panel of
records. Negative binomial regressions assessed trends in overall HIV testing
and returning within 3 and 6 months. Annualised proportions of return tests
(2007-2012) were compared using two-sample z tests.
RESULTS:
Across
18 538 tests among 7117 high-risk MSM attending primary care clinics in
Melbourne (2007-2013), the number of annual HIV tests increased (p<0.01).
Between 2007 and 2012 annualised proportions of tests with a subsequent test
within 3 and 6 months also increased (p<0.01); however, by 2012 only 36.4%
and 15.1% of tests were followed by another test inside 6 and 3 months,
respectively.
CONCLUSIONS:
Repeat
testing among high-risk MSM in Australia remains unacceptably low, with recent
modest increases in testing unlikely to deliver meaningful prevention impact.
Removing known barriers to HIV testing is needed to maximise the potential
benefit of test and treat-based HIV prevention.
Sex Transm Infect. 2016 Jan 22. pii: sextrans-2015-052421. doi: 10.1136/sextrans-2015-052421.
- 1Centre for Population Health, Burnet Institute, Melbourne, Victoria, Australia School of Public Health and Preventive Medicine, Monash University, Alfred Hospital, Melbourne, Victoria, Australia.
- 2Centre for Population Health, Burnet Institute, Melbourne, Victoria, Australia.
- 3Melbourne Sexual Health Centre, Alfred Health, Carlton, Victoria, Australia Central Clinical School, Monash University, Alfred Hospital, Melbourne, Victoria, Australia.
- 4Victorian Infectious Disease Reference Laboratory, Melbourne, Victoria, Australia.
- 5Centre for Population Health, Burnet Institute, Melbourne, Victoria, Australia Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
- 6Centre for Population Health, Burnet Institute, Melbourne, Victoria, Australia School of Public Health and Preventive Medicine, Monash University, Alfred Hospital, Melbourne, Victoria, Australia Department of Infectious Disease, Alfred Health, Alfred Hospital, Melbourne, Victoria, Australia.
No comments:
Post a Comment